| |
| |
|
| Insider
Information: |
Chodakewitz Jeffrey |
| Relationship: |
Director |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
81,813 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$31,978,674 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
81,813 |
|
|
| Total
Value |
$31,978,674 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP GMDA, CMO |
2018-02-12 |
69,663 |
|
0 |
Premium* |
|
|
Adicet Bio, Inc |
ACET |
Director |
2023-06-01 |
5,900 |
2023-06-01 |
0 |
Premium* |
|
|
Schrodinger, Inc. |
SDGR |
Director |
2023-06-15 |
6,250 |
2023-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2018-02-01 |
4 |
AS |
$167.44 |
$318,136 |
D/D |
(1,900) |
52,524 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2018-02-02 |
4 |
AS |
$165.23 |
$298,329 |
D/D |
(1,796) |
52,524 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$6,413,113 |
D/D |
(39,833) |
121,324 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2018-02-05 |
4 |
AS |
$158.32 |
$580,304 |
D/D |
(3,594) |
52,524 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-07-21 |
4 |
AS |
$158.08 |
$1,109,022 |
D/D |
(6,900) |
114,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2018-01-16 |
4 |
AS |
$155.80 |
$270,358 |
D/D |
(1,719) |
54,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-10-16 |
4 |
AS |
$153.42 |
$266,610 |
D/D |
(1,718) |
114,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-08-03 |
4 |
AS |
$153.29 |
$554,149 |
D/D |
(3,594) |
114,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-08-02 |
4 |
AS |
$152.50 |
$276,811 |
D/D |
(1,796) |
114,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-10-02 |
4 |
AS |
$151.04 |
$521,198 |
D/D |
(3,437) |
114,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2018-01-02 |
4 |
AS |
$149.65 |
$521,895 |
D/D |
(3,438) |
54,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2018-02-12 |
4 |
AS |
$149.21 |
$772,493 |
D/D |
(5,122) |
69,663 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-11-03 |
4 |
AS |
$144.69 |
$520,016 |
D/D |
(3,594) |
54,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-11-02 |
4 |
AS |
$143.54 |
$259,982 |
D/D |
(1,796) |
54,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-10-31 |
4 |
AS |
$142.38 |
$8,703,161 |
D/D |
(60,000) |
54,424 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-06-21 |
4 |
AS |
$132.87 |
$685,211 |
D/D |
(5,157) |
122,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2015-11-18 |
4 |
AS |
$130.00 |
$1,340,950 |
D/D |
(10,315) |
100,562 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-07-17 |
4 |
AS |
$129.61 |
$74,402 |
D/D |
(573) |
122,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-07-03 |
4 |
AS |
$127.38 |
$439,379 |
D/D |
(3,438) |
122,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-06-01 |
4 |
AS |
$126.87 |
$654,015 |
D/D |
(5,155) |
122,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2015-07-02 |
4 |
AS |
$126.69 |
$296,357 |
D/D |
(2,291) |
100,562 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2017-05-02 |
4 |
AS |
$121.05 |
$1,086,908 |
D/D |
(8,979) |
122,511 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2015-01-02 |
4 |
AS |
$119.03 |
$280,735 |
D/D |
(2,291) |
84,500 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2015-04-02 |
4 |
AS |
$115.12 |
$264,601 |
D/D |
(2,291) |
100,562 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP GMDA, CMO |
• – – |
2014-10-28 |
4 |
AS |
$115.00 |
$395,370 |
D/D |
(3,438) |
9,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
